Filing Details
- Accession Number:
- 0001144204-17-053025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-18 16:15:30
- Reporting Period:
- 2017-10-17
- Accepted Time:
- 2017-10-18 16:15:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1138776 | Aevi Genomic Medicine Inc. | GNMX | Biological Products, (No Disgnostic Substances) (2836) | 980217544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1247015 | J Sol Barer | C/O Aevi Genomic Medicine, Inc. 435 Devon Park Drive, Suite 715 Wayne PA 19087 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-10-17 | 421,032 | $1.26 | 1,028,032 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (right to buy) | Acquisiton | 2017-10-17 | 74,912 | $0.00 | 74,912 | $2.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 74,912 | 2017-10-17 | 2022-10-17 | No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 153,846 | Indirect | By: Wife |
| Common Stock | 365,854 | Indirect | By: grantor retained annuity trust |
Footnotes
- Shares purchased by the wife of the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- By the Sol J. Barer 2013 Grantor Retained Annuity Trust No. IV.
Billionaire Hedge Funds
